WinstonWınston
Humana logo

Humana

HUM
29
Medical - Healthcare Plans · Healthcare
Price
$400.00
+13.52 (+3.50%)
Market Cap
$48.02B
Winston Score
29
Winston is worried
Below-average fundamentals — multiple weak pillars.

Share count falling — buybacks

6.6% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 129.4M (2021) → 120.8M (2025)

Humana is one of the largest health insurance companies in the United States. It sells health insurance plans to individuals, employers, and government programs. Its biggest business is Medicare Advantage, which are private health plans sold to Americans aged 65 and older — Humana is one of the top two providers of these plans in the country.

Humana makes most of its money by collecting monthly premiums from members and then paying their medical bills. It operates almost entirely in the United States and covers roughly 17 million members across its various plans. Its large Medicare Advantage membership base gives it scale and brand recognition with older Americans, but the company faces serious pressure when medical costs rise faster than the premiums it collects — a dynamic that has squeezed its margins recently and is the central risk investors are watching closely.

Winston Score History

Politician Trades

29 trades / 12mo

13 Congressional buys and 16 sells on HUM in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+23.5% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-4.5% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

0.2%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

$5.0B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Humana is a rare growth stock that's already generating positive cash flow while growing at 23%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
15.0%
Thin — 15.0% gross margin
Operating Margin
4.0%
Thin — 4.0% operating margin
ROCE
4.8%
Weak — 4.8% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+14.1%
Fast-growing sales (14.1% YoY)
EPS YoY
-33.9%
Earnings shrinking (-33.9% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
163%
Turns 163% of profit into real cash
FCF Margin
0.9%
Thin free cash flow (0.9%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.75
Moderate — manageable debt (0.75)
Interest Cover
2.08x
Tight — interest eats into profit (2.1x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
42.6x
Pricey — P/E 42.6

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+28.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (42.6 → 13.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
0.98%
Small dividend — 0.98% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial